The Human Tissue Authority's annual conference took place on Monday 12 November at Church House in Westminster, London.
The conference was a full day event; from 10.00 to 16.00 and was aimed at health professionals and those working at our licensed establishments. Unlike previous years, it was not be coupled with our public Authority meeting, as this took place in the Summer of 2018.
The theme of this year’s event was ‘Regulation in an era of innovation and political uncertainty’.
This theme was chosen as we recognised that the context of this conference was set at a time of uncertain political climate and that the potential for new developments and therapies for patients often comes from quite unexpected quarters. We invited attendees to take part in discussions on how the HTA can create the right regulatory response to future challenges and continue to build public confidence.
The conference was held in two parts:
In the morning, we had presentations from the following speakers.
- Dr Nicole Mather, Director of Life Sciences and Healthcare at Deloitte Strategy.
- Judge Mark Lucraft QC, Chief Coroner for England and Wales.
- Professor Bobbie Farsides, Professor of Clinical and Biomedical Ethics at Brighton and Sussex Medical School.
- Phil Walton, Regional Manager at NHS Blood and Transplant Wales.
- Dr Janet Messer, Director of the Approvals Service at the Health Research Authority.
In the afternoon, we hosted a table discussion session for attendees to discuss HTA-related topics with our staff and their peers. This session also included a HTA presentation from Nicolette Harrison, Director of Regulatory Delivery at the Human Tissue Authority.